Skip to main content
Clinical Trials/NCT06108167
NCT06108167
Recruiting
Not Applicable

Percutaneous Imaging-guided Cryoblation of the Anterior Abdominal Wall Endometriosis Scars

University Hospital, Strasbourg, France1 site in 1 country29 target enrollmentMay 5, 2023
ConditionsEndometriosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometriosis
Sponsor
University Hospital, Strasbourg, France
Enrollment
29
Locations
1
Primary Endpoint
Efficacy of cryotherapy on parietal endometriosis lesions was assessed using the a visual analogue scale (VAS) ranging from 0 to 10.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Endometriosis is a common condition affecting 10% of women. It is characterized by the presence of ectopic endometrial cells. This pathology most frequently develops in the ovaries, utero-sacral ligaments and pelvic peritoneum, but also in the recto-sigmoid. Rarely, these lesions are found outside the pelvis, and even more exceptionally in the abdominal wall (in 0.03 to 1% of cases).

Cryotherapy has already been used for many years to treat soft tissue tumors (kidney and prostate tumors). It has also been successfully used by interventional radiologists to treat parietal desmoid tumors. After discussions with radiologists, given the similarity of location and extension of wall endometriosis lesions with desmoid tumours, the successes observed, and the scarcity of studies in the literature, it seemed appropriate to the investigators to study this new therapy.

The aim of this study was to investigate the efficacy of cryotherapy on parietal endometriosis lesions.

Registry
clinicaltrials.gov
Start Date
May 5, 2023
End Date
November 5, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult woman (≥18 years old) Having benefited from cryotherapy of an abdominal wall endometriosis nodule between January 6, 2020 and January 2,
  • Subject not objecting to the reuse of their data for the purposes of this research

Exclusion Criteria

  • Subject having expressed its opposition to the reuse of its data for scientific research purposes.

Outcomes

Primary Outcomes

Efficacy of cryotherapy on parietal endometriosis lesions was assessed using the a visual analogue scale (VAS) ranging from 0 to 10.

Time Frame: Before and 6 months after the cryotherapy

Study Sites (1)

Loading locations...

Similar Trials